NCT01732497已完成不适用
A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Miramar Labs
- 入组人数
- 56
- 试验地点
- 5
- 主要终点
- Patients with successful hair reduction
研究概览
简要总结
The purpose of this study is to evaluate hair reduction in the underarms in patients treated with the miraDry System.
详细描述
This study is designed to quantify the amount of hair reduction in patients treated with the miraDry System in the axilla. Hair counts will be assessed before and after treatments including at follow up visits.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years of age
- •Visible underarm hair (prefer light colored hair; blonde, red, gray)
排除标准
- •Secondary Axillary Hyperhidrosis
- •Prior surgery and/or Botox Injections in axillae
- •Pacemaker or requires supplemental oxygen
结局指标
主要结局
Patients with successful hair reduction
时间窗: 3 months
Percentage of patients that show a \>=30% reduction in underarm hair at the 3 month visit compared to baseline.
次要结局
- Patients with successful hair reduction(12 months)
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Hair Count Reduction Verification Study With the LightSheer Duet HS HandpieceHair RemovalNCT01282866Lumenis Be Ltd.35
终止
2 期
A Study of Secukinumab for the Treatment of Alopecia AreataAlopecia AreataNCT02599129Icahn School of Medicine at Mount Sinai11
进行中(未招募)
2 期
Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.Male Androgenetic AlopeciaNCT05599243Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal45
已完成
2 期
Study of effectiveness and safety on the hair loss restraint by scalp cooling with scalp cooling device in the breast cancer chemotherapyBreast cancerJPRN-UMIN000031534ational Hospital Organization Kyushu Cancer Center120
暂停
2 期
Hair loss restraint by scalp cooling enforcementBreast cancerJPRN-jRCTs072180051TOKUNAGA Eriko21
